Presentation is loading. Please wait.

Presentation is loading. Please wait.

Technical Leadership & Research Division of HIV/AIDS, USAID/Washington

Similar presentations


Presentation on theme: "Technical Leadership & Research Division of HIV/AIDS, USAID/Washington"— Presentation transcript:

1 Technical Leadership & Research Division of HIV/AIDS, USAID/Washington
INTEGRATING MENTAL HEALTH SERVICES INTO HIV CARE AND PREVENTION: The Time has Come for a More Holistic Approach By Jude Awuba, MPH,CHES Technical Leadership & Research Division of HIV/AIDS, USAID/Washington

2 Objectives To review key mental health (MH) issues in the continuum of care for people living with HIV (PLHIV) To provide a framework for integrating mental health services into HIV/AIDS interventions To discuss a public health approach to addressing the co-occurrence of MH and HIV

3 Background Antiretroviral Therapy (ART) has led to a reduction of AIDS mortality The goal of HIV treatment and care has shifted from delaying death to achieving optimal health outcomes Syndemic occurrence of MH, substance abuse (SA) and HIV

4 Correlation between MH and HIV/AIDS
Premorbid Co-morbid Psychopathology Psychopathology Prevention Treatment and Care General Population MH SA PLHIV Limited access to care Low adherence to ART Higher mortality High risk behavior

5 Bi-directional Relationship Between MH and HIV/AIDS
Mental health increases risk for HIV HIV increases risk for mental health Effective treatment for mental health can decrease HIV transmission Effective treatment of mental health can improve outcome for PLHIV

6 Dimensions of Mental Health
Biomedical Behavioral Psychosocial

7 Co-occurrence of MH and HIV/AIDS
Biomedical Sub-cortical degeneration caused by HIV virus Brain damage as result of opportunistic infection Pharmacologic effects of treatment

8 Co-occurrence of MH and HIV/AIDS
Behavioral Injection drug use (IDU)—needle sharing and trading sex for drugs Alcohol abuse—high risk behavior, unsafe sex and inconsistent/incorrect condom use

9 Co-occurrence of MH and HIV/AIDS
Psychosocial Patients’ awareness of the prognosis and fatal outcome of the disease Stigma against PLHIV Worries and anxieties arising from socio-economic repercussions of health status

10 MH and Clinical Stages of progression of HIV/AIDS
Time (Years) 0-1 1-2 2-10 3-15 Death HIV Stage At Infection I Initial Diagnosis II Asymptomatic Phase III & IV AIDS After Death Mental Health Substance Abuse Post-Traumatic Stress Disorder Acute stress reactions Adjustment disorders Panic disorders Delirium Suicide Depression Substance abuse Anxiety disorders Personality changes HIV Dementia Psychosis Mania Seizures

11 Global Prevalence of MH in PLHIV
10% of HIV-infected patients worldwide are IDUs 70% patients with HIV suffer from an acute psychiatric complication during the course of the illness 90% of people who have recently been diagnosed with HIV infection suffer from acute stress disorder Aceijas C, Stimson , GV., Hickman, M. Global Overview of Injection Drug Use and HIV infection among injection drug users. AIDS 2004, 19;18 (17): Adewuya, A.O. Afolabi, B.A, Ogundele, A O. Ajibare, and B.F Oladipo, “Psychiatric Disorders Among the HIV-Positive Population in Nigeria: A control Study.” J , Psychosom Res 63, no (2007):

12 Gaps in MHS in PLHIV Mental health conditions for PLHIV are under diagnosed and under treated In resource-limited countries: High burden of HIV/AIDS Limited capacity of MHS delivery

13 Gaps in MHS in PLHIV Country Study Population MH Prevalence
HIV/AIDS Prevalence Uganda PLHIV in a clinic in Western Uganda HIV Dementia- 47% 5.4% South Africa Random sample of 900 PLHIV MH disoder-43.7% 18.1% Kenya PLHIV attending clinic in Western Kenya Alcohol Abuse- 55% 7.1% Nakasujja, N., Musisi, S., Robertson, K., Wong, M., Sacktor, N. & Ronald, A. (2005) Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. Journal of Neurovirology 11(supplement 3), pp. S26–S29. Freeman, M ., Nkomo N., Karafar, Z. & Kelly K. (n.d). Factors Associated with the prevalence of mental disorder in people living with HIV/AIDS in South Africa. Aids Care, 19 (10), Geetanjali , C., Seth, H., and Richmond D. Substance Abuse and Psychiatric Disorders in HIV –Positive Patients: Epidemiology and Impact on Antiretroviral Therapy. Drugs 2006;66 (6):

14 Impact of MH on HIV/AIDS Prevention, Treatment and Care Outcomes
High risk behavior Higher rates of infections Higher rates of transmission Treatment and Care Limited access to care Low uptake and adherence of ART High failure rate to routine checks Clinical Outcomes HIV Dementia Rapid AIDS progression Higher mortality

15 SA and HIV/AIDS Infection
Newly diagnosed HIV/AIDS cases resulting from IDU in US in 2005 Whites Blacks Hispanics 50 Females 40 Males* 33 30 30 30 29 *Includes MSM who are IDUs. 24 New Cases of HIV/AIDS (%) 20 17 10 Centers for Disease Control and Prevention. Available at: resources/reports/2005report. Accessed January 9, 2008

16 MH and Adherence to ART Attribute % of Non-adherence to ART
Active alcohol abuse Active injection drug use Homelessness Depression History of injection drug use History of alcohol abuse Motherhood of small children Lower educational level Lower income level Minority race Stone V, et al. Curr HIV/AIDS Rep. 2005;2:

17 Depression and Mortality in PLHIV
HIV-Related Mortality 1.0 0.9 Cumulative Survival 0.8 Limited depression Intermittent depression Study assessed association of depressive symptoms with HIV-related mortality and decline in CD4+ cell counts in HERS cohort (N = 765) Depression (CES-D) defined as limited, intermittent, or chronic Multivariate analysis: increased RR of mortality in women with chronic depressive symptoms (2.0; 95% CI: ) vs those with limited or no symptoms Mortality in patients with CD4+ < 200 Chronic depression: 54%( RR: 4.3; 95% CI: ) vs limited depression Intermittent depression: 48% (RR: 3.5; 95% CI: ) vs limited depression Limited depression: 21% Chronic depression 0.7 1 2 3 4 5 6 7 Total Time in Study (Yrs) Ickovics JR, et al. JAMA. 2001;285: 17

18 Adapted WHO Framework for Integrating MHS in HIV/AIDS Interventions
Level I: Treatment of mental disorder Level II: Supportive behavioral interventions for at risk group Level III: Community mobilization and prevention Educational sessions, stigma reduction, health promotion campaigns, home visits, focus groups Supportive counseling, peer support groups, coping, stress management, life skills training Psychotherapeutic or pharmacologic treatment modalities WHO Framework recognizes the need for multiple levels of MHS delivery in HIV/AIDS interventions. A balance of community based and hospital based services has been shown to be the most effective form of comprehensive mental health care Trained mental health professionals or primary care physicians Trained counselor or peer support volunteer Trained community health care workers, social workers, CBOs, NGOs and FBOs

19 WHO Framework: Key Features
Multiple levels of intervention both facility and community-based services Interventions are community and culturally driven to fit local conditions Coordination of services across multiple levels and integration with other HIV services Emphasis on prevention of disease and promotion of health Focus on communities rather than individuals

20 Challenges and Opportunities : Integrating Mental Health into HIV/AIDS care
Limited capacity of the healthcare system Integration of mental health into primary care and HIV/AIDS programming Inadequate MH providers Pre and in-service training of primary care providers Stigma associated with MH and HIV Community mobilization and advocacy Treatment of MH at primary care level Fragmented healthcare system Strengthening linkages and referral system Disease management approach Disease prevention and health promotion Knowledge gap on mental health and psychosocial needs for PLHIV Research and pilot projects to inform programmatic interventions

21 Outcome of MH Interventions in Prevention and Treatment of PLHIV
Moore RD., Keruly J (2004). Difference in HIV disease progression by injecting drug use in HIV-infected persons in care. J Acquir Immune Defic Syndr 35 (1):46-51.

22 Outcome of MH Interventions in Prevention and Treatment of PLHIV
Source L Lourdes Y., Maravi et al, (2005). Antidepressant Treatment Improves Adherence to Antiretroviral Therapy Among Depressed HIV-infected Patients. J Acquir Immune Defic Syndr (38):

23 10 Reasons for Integrating MH into HIV Prevention and Treatment
Reduce new infections Reduce onward transmission (prevention with positives) Increase access to care Increase uptake to ART Reduce rate of loss to follow up Increase adherence to ART Reduce morbidity and mortality of PLHIV Cost-effectiveness Integrated services— two- in-one Strengthen linkages and referral system

24 Conclusion Reduce new infection and onward transmission
Better health outcome for PLHIV Synergistic opportunities Actively addressing mental healthhas the potential to reduce behaviors that lead to risky sexual behavior and HIV transmission, while also positively impacting the health of those living with HIV/AIDS Integration of mental health services into existing HIV/AIDS programs could provide a viable method to capitalize on existing infrastructure while synergistically improving health outcomes

25 Thank you


Download ppt "Technical Leadership & Research Division of HIV/AIDS, USAID/Washington"

Similar presentations


Ads by Google